Back to Search
Start Over
KemPharm Announces Initiation of Phase 2 Clinical Trial Investigating KP1077 for the Treatment of Idiopathic Hypersomnia (IH)
- Source :
- Plus Company Updates. December 23, 2022
- Publication Year :
- 2022
-
Abstract
- CELEBRATION, Fla: KemPharm has issued the following news release: KemPharm, Inc. (NasdaqGS: KMPH) (KemPharm, or the Company), a rare disease therapeutics company focused on the development of treatments for rare [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.731282688